Study testing a new valve delivered through a blood vessel
Part of Heart & circulation clinical trials.
This trial studies Prizvalve Pro™, a new transcatheter (catheter-based) aortic valve replacement, for people with severe aortic valve narrowing who are too high-risk for standard surgery. It may help your heart work better and improve symptoms by replacing the failing valve without open-heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 65 or older
- Have severe aortic valve stenosis with symptoms, based on heart ultrasound measurements
- Have heart function class NYHA II or higher and life expectancy over 12 months
- Have heart anatomy that fits this catheter valve procedure
- Be considered unsuitable for standard surgery by heart surgeons, or refuse surgery because it’s high risk
- Be able to understand the study, sign consent, and come for follow-up tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows how the VitaFlow heart valve works in people age 70+ who have severe, narrowed aortic valves and cannot safely get open-heart valve surgery. It’s meant to see whether the device improves outcomes and is safe over time.
This trial tests a new delivery system (VitaFlow Liberty Flex) for placing a replacement aortic valve in people with severe aortic stenosis. It is designed for patients whose heart anatomy (a steep angle between the heart and aorta) makes the procedure more challenging.
This trial is testing a new, less invasive way to replace a narrowed aortic valve using a special device. The goal is to help improve blood flow and reduce symptoms like chest pain and shortness of breath.
This study tests a new replacement valve for the aortic valve, which controls blood flow from the heart. It may help people with severe aortic valve narrowing or leaking who need surgery.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This study tests a new replacement valve for the aortic heart valve, delivered through a catheter (a thin tube) — a procedure called TAVR. It is for people who have severe aortic stenosis and are not good candidates for open-heart surgery.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.